Paralytics


Neuromuscular-blocking agents also known as paralytics block neuromuscular transmission at neuromuscular junction, causing loss of motion of skeletal muscles. This is accomplished similarly by acting presynaptically through the inhibition of acetylcholine (ACh) synthesis and by acting postsynaptically at the acetylcholine receptors of the motor nerve end-plate. While a few medications act presynaptically, (for example, botulinum toxin and tetanus poison), those of current clinical significance work postsynaptically. Because the appropriate dose of neuromuscular-blocking medication may paralyze muscles required for breathing (i.e., the diaphragm), mechanical ventilation should to be provided to maintain adequate respiration.


    Related Conference of Paralytics

    July 21-22, 2025

    8th World Congress on Surgeons

    Barcelona, Spain
    July 24-25, 2025

    11th International Conference on Surgeons

    Paris, France
    November 19-20, 2025

    16th European Conference on Surgery & Cosmetology

    Barcelona, Spain
    December 04-05, 2025

    8th Annual Summit on Surgery and Transplantation

    Paris, France

    Paralytics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in